Aclaris Therapeutics Shares Outstanding 2014-2018 | ACRS

Current and historical number of shares outstanding for Aclaris Therapeutics (ACRS) from 2014 to 2018. Diluted shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options.
Aclaris Therapeutics Annual Shares Outstanding
(Millions of US $)
2017 $28
2016 $21
2015 $6
2014 $2
2013 $1
Aclaris Therapeutics Quarterly Shares Outstanding
(Millions of US $)
Q2 2018 $31
Q1 2018 $31
Q4 2017 $28
Q3 2017 $29
Q2 2017 $27
Q1 2017 $26
Q4 2016 $21
Q3 2016 $21
Q2 2016 $21
Q1 2016 $20
Q4 2015 $6
Q3 2015 $2
Q2 2015 $2
Q1 2015 $2
Q4 2014 $0
Q3 2014 $2
Q4 2013 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.536B $0.002B
Aclaris Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing drugs to met needs in dermatology. Its drug candidate consists of A-101, a high-concentration hydrogen peroxide topical solution which is being developed as a prescription treatment for seborrheic keratosis a common non-malignant skin tumor and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts which are in different clinical trial. Aclaris Therapeutics, Inc. is headquartered in Malvern, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $52.162B 11.05
Zoetis (ZTS) United States $44.183B 32.06
Grifols (GRFS) Spain $14.285B 18.51
Neurocrine Biosciences (NBIX) United States $10.717B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $10.639B 15.65
Nektar Therapeutics (NKTR) United States $10.305B 12.05
Sage Therapeutics (SAGE) United States $6.923B 0.00
Ionis Pharmaceuticals (IONS) United States $6.685B 0.00
United Therapeutics (UTHR) United States $5.514B 7.08
Catalent (CTLT) United States $5.351B 24.92
FibroGen (FGEN) United States $5.056B 0.00
Loxo Oncology (LOXO) United States $4.854B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.214B 16.32
Madrigal Pharmaceuticals (MDGL) United States $3.575B 0.00
Endo (ENDP) Ireland $3.505B 5.03
USANA Health Sciences (USNA) United States $3.147B 27.72
Heron Therapeutics (HRTX) United States $3.008B 0.00
Aerie Pharmaceuticals (AERI) United States $2.917B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.882B 0.00
Tilray (TLRY) United States $2.370B 0.00
Spectrum Pharmaceuticals (SPPI) United States $2.310B 0.00
Xencor (XNCR) United States $2.242B 0.00
PTC Therapeutics (PTCT) United States $2.039B 0.00
Portola Pharmaceuticals (PTLA) United States $1.926B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.882B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.821B 22.26
Zogenix (ZGNX) United States $1.797B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.544B 0.00
Corcept Therapeutics (CORT) United States $1.539B 23.68
Impax Laboratories (AMRX) United States $1.500B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.487B 0.00
TESARO (TSRO) United States $1.464B 0.00
ImmunoGen (IMGN) United States $1.332B 0.00
Esperion Therapeutics (ESPR) United States $1.235B 0.00
TherapeuticsMD (TXMD) United States $1.213B 0.00
Endocyte (ECYT) United States $1.115B 0.00
Karyopharm Therapeutics (KPTI) United States $1.095B 0.00
Radius Health (RDUS) United States $1.020B 0.00
Tricida (TCDA) United States $0.953B 0.00
Flexion Therapeutics (FLXN) United States $0.868B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.798B 0.00
OptiNose (OPTN) United States $0.797B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.706B 0.00
CASI Pharmaceuticals (CASI) United States $0.683B 0.00
GlycoMimetics (GLYC) United States $0.622B 0.00
Siga Technologies (SIGA) United States $0.621B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.608B 0.00
Dova Pharmaceuticals (DOVA) United States $0.606B 0.00
Collegium Pharmaceutical (COLL) United States $0.599B 0.00
ArQule (ARQL) United States $0.594B 0.00
ChemoCentryx (CCXI) United States $0.587B 35.15
Lannett Co Inc (LCI) United States $0.515B 4.74
Odonate Therapeutics (ODT) United States $0.512B 0.00
Majesco Entertainment (COOL) United States $0.507B 0.00
Translate Bio (TBIO) United States $0.472B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.464B 0.00
Depomed (DEPO) United States $0.461B 0.00
Akebia Therapeutics (AKBA) United States $0.458B 0.00
Forty Seven (FTSV) United States $0.454B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.454B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.434B 0.00
Dermira (DERM) United States $0.419B 0.00
Xeris Pharmaceuticals (XERS) United States $0.405B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.388B 0.00
Concert Pharmaceuticals (CNCE) United States $0.384B 0.00
Aquestive Therapeutics (AQST) United States $0.384B 0.00
ElectroCore (ECOR) United States $0.374B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.351B 23.91
Mast Therapeutics (SVRA) United States $0.344B 0.00
Neon Therapeutics (NTGN) United States $0.342B 0.00
Minerva Neurosciences (NERV) United States $0.328B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.305B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.286B 0.00
Achaogen (AKAO) United States $0.281B 0.00
Jounce Therapeutics (JNCE) United States $0.273B 0.00
Opexa Therapeutics (ACER) United States $0.271B 0.00
Zafgen (ZFGN) United States $0.270B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.270B 0.00
Aratana Therapeutics (PETX) United States $0.245B 0.00
Tyme Technologies (TYME) United States $0.243B 0.00
Ocular Therapeutix (OCUL) United States $0.240B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.237B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.235B 0.00
IMV INC (IMV) Canada $0.228B 0.00
DURECT (DRRX) United States $0.227B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.221B 0.00
Ardelyx (ARDX) United States $0.200B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.199B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.195B 0.00
Adherex Technologies (FENC) United States $0.188B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.188B 0.00
Neos Therapeutics (NEOS) United States $0.185B 0.00
Galectin Therapeutics (GALT) United States $0.183B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.182B 0.00
MediWound (MDWD) Israel $0.174B 0.00
Nature's Sunshine Products (NATR) United States $0.172B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.170B 0.00
Immune Design (IMDZ) United States $0.169B 0.00
Cardiome Pharma (CORV) Canada $0.167B 0.00
Aldeyra Therapeutics (ALDX) United States $0.163B 0.00
ContraFect (CFRX) United States $0.161B 0.00
Calithera Biosciences (CALA) United States $0.160B 0.00
ProNAi Therapeutics (SRRA) Canada $0.152B 0.00
Melinta Therapeutics (MLNT) United States $0.152B 0.00
Molecular Templates (MTEM) United States $0.144B 0.00
Redhill Biopharma (RDHL) Israel $0.138B 0.00
MEI Pharma (MEIP) United States $0.136B 0.00
KalVista Pharmaceuticals (KALV) United States $0.134B 0.00
Forward Pharma (FWP) Denmark $0.131B 0.00
Juniper Pharmaceuticals (JNP) United States $0.130B 0.00
SteadyMed (STDY) Israel $0.126B 0.00
Iterum Therapeutics (ITRM) Ireland $0.123B 0.00
Recro Pharma (REPH) United States $0.122B 0.00
Infinity Pharmaceuticals (INFI) United States $0.120B 0.00
Rafael Holdings (RFL) United States $0.116B 0.00
CTI BioPharma (CTIC) United States $0.113B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.109B 0.00
Otonomy (OTIC) United States $0.107B 0.00
Affimed (AFMD) Germany $0.100B 0.00
Nivalis Therapeutics (ALPN) United States $0.097B 0.00
BioLineRx (BLRX) Israel $0.094B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.093B 0.00
Champions Oncology (CSBR) United States $0.084B 0.00
Natural Alternatives (NAII) United States $0.075B 9.61
KemPharm (KMPH) United States $0.073B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.071B 0.00
Trillium Therapeutics (TRIL) Canada $0.071B 0.00
Novan (NOVN) United States $0.067B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.067B 0.00
SCYNEXIS (SCYX) United States $0.065B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.054B 0.00
Capnia (SLNO) United States $0.053B 0.00
Genocea Biosciences (GNCA) United States $0.051B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.048B 0.00
Mannatechorporated (MTEX) United States $0.043B 22.91
Avenue Therapeutics (ATXI) United States $0.043B 0.00
Heat Biologics (HTBX) United States $0.043B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.043B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.038B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.035B 0.00
Onconova Therapeutics (ONTX) United States $0.034B 0.00
Biomerica (BMRA) United States $0.033B 0.00
IsoRay (ISR) United States $0.033B 0.00
Lipocine (LPCN) United States $0.033B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.031B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.030B 0.00
Xenetic Biosciences (XBIO) United States $0.028B 0.00
HANCOCK JAFFE (HJLI) United States $0.027B 0.00
Shineco (TYHT) China $0.026B 2.23
XTL Biopharmaceuticals (XTLB) Israel $0.024B 0.00
Can-Fite Biopharma (CANF) Israel $0.024B 0.00
NanoViricides (NNVC) United States $0.023B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.022B 0.00
Regulus Therapeutics (RGLS) United States $0.022B 0.00
Aviragen Therapeutics (VXRT) United States $0.022B 0.00
Cyanotech (CYAN) United States $0.021B 20.43
Aradigm (ARDM) United States $0.021B 0.00
Egalet (EGLT) United States $0.021B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
ESSA Pharma (EPIX) Canada $0.018B 0.00
Bio-Path Holdings (BPTH) United States $0.017B 0.00
Midatech Pharma (MTP) United Kingdom $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.015B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.015B 0.00
Skyline Medical (AIPT) United States $0.015B 0.00
Intellipharmaceutics (IPCI) Canada $0.014B 0.00
India Globalization Capital (IGC) United States $0.013B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.011B 0.00
PharmAthene (ALT) United States $0.011B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.011B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.009B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.009B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.008B 0.00
Pain Therapeutics (PTIE) United States $0.008B 0.00
RXi Pharmaceuticals (RXII) United States $0.007B 0.00
Apricus Biosciences (APRI) United States $0.007B 0.00
Biostar Pharmaceuticals (BSPM) China $0.005B 2.69
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Aralez Pharmaceuticals (ARLZ) Canada $0.004B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00